High prevalence of blood-borne virus infections and high-risk behaviour among injecting drug users in Tallinn, Estonia.
The HIV epidemic in Estonia is rapidly expanding, and injection drug users (IDUs) are the major risk group contributing to the expansion. A convenience sample of 159 IDUs visiting syringe-exchange programmes (SEPs) was selected to quantify the association of HIV-risk behaviours and blood-borne infections. A high prevalence of HIV, hepatitis B core antibody (HBVcore), hepatitis B surface antigen (HbsAg) and hepatitis C virus antibodies (56, 85.1, 21.3, and 96.2%, respectively) was associated with high-risk injections, unsafe sexual behaviour and alcohol abuse. These findings emphasize the importance of evidence-based secondary prevention among the HIV-infected, especially given the uncertain sustainability of antiretroviral and substance abuse treatments.
Uusküla
Anneli
A
Department of Public Health, University of Tartu, Estonia. anneli.uuskula@ut.ee
McNutt
Louise Anne
LA
Dehovitz
Jack
J
Fischer
Krista
K
Heimer
Robert
R
D000293:Adolescent; D000328:Adult; D018562:Disease Transmission, Infectious / Q000517:prevention & control; D004957:Estonia / Q000453:epidemiology; D005260:Female; D006678:HIV / Q000302:isolation & purification; D015658:HIV Infections / Q000097:blood / Q000453:epidemiology* / Q000635:transmission; D016174:Hepacivirus / Q000302:isolation & purification; D006509:Hepatitis B / Q000097:blood / Q000453:epidemiology* / Q000635:transmission; D006515:Hepatitis B virus / Q000302:isolation & purification; D006526:Hepatitis C / Q000097:blood / Q000453:epidemiology* / Q000635:transmission; D006801:Humans; D008297:Male; D018671:Needle-Exchange Programs; D015995:Prevalence; D012309:Risk-Taking; D015819:Substance Abuse, Intravenous / Q000097:blood / Q000453:epidemiology / Q000821:virology*; D011795:Surveys and Questionnaires